Sonoma Biotherapeutics to Occupy 83,000 SQFT R&D Development in Seattle

SEATTLE, Wash. –  Cushman & Wakefield and JLL today jointly announced that the firms have represented Sonoma Biotherapeutics, Inc. in a long-term lease agreement to develop an approximately 83,000-square-foot Research and Development (R&D) and Manufacturing Center in Seattle, Washington. Sonoma Bio is a clinical-stage biotechnology company focused on developing engineered regulatory T cell (Treg) therapies […]